These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25526642)

  • 1. Effect of hemodialysis on plasma glucose profile and plasma level of liraglutide in patients with type 2 diabetes mellitus and end-stage renal disease: a pilot study.
    Osonoi T; Saito M; Tamasawa A; Ishida H; Tsujino D; Nishimura R; Utsunomiya K
    PLoS One; 2014; 9(12):e113468. PubMed ID: 25526642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy.
    Jin YP; Su XF; Yin GP; Xu XH; Lou JZ; Chen JJ; Zhou Y; Lan J; Jiang B; Li Z; Lee KO; Ye L; Ma JH
    J Diabetes Complications; 2015 Apr; 29(3):395-9. PubMed ID: 25681043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving Dialysis.
    Bomholt T; Idorn T; Knop FK; Jørgensen MB; Ranjan AG; Resuli M; Hansen PM; Borg R; Persson F; Feldt-Rasmussen B; Hornum M
    Nephron; 2021; 145(1):27-34. PubMed ID: 33105146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus.
    Derosa G; Libetta C; Esposito P; Borettaz I; Tinelli C; D'Angelo A; Maffioli P
    J Diabetes Complications; 2015; 29(8):1136-41. PubMed ID: 26387810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized Trial.
    Idorn T; Knop FK; Jørgensen MB; Jensen T; Resuli M; Hansen PM; Christensen KB; Holst JJ; Hornum M; Feldt-Rasmussen B
    Diabetes Care; 2016 Feb; 39(2):206-13. PubMed ID: 26283739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of liraglutide treatment in Japanese type 2 diabetes patients after acute myocardial infarction: A non-randomized interventional pilot trial.
    Kajiwara M; Tanaka A; Kawasaki T; Nakao K; Sakamoto T; Toyoda S; Inoue T; Koga N; Node K
    J Cardiol; 2017 Mar; 69(3):511-517. PubMed ID: 27894787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial.
    Davies MJ; Bain SC; Atkin SL; Rossing P; Scott D; Shamkhalova MS; Bosch-Traberg H; Syrén A; Umpierrez GE
    Diabetes Care; 2016 Feb; 39(2):222-30. PubMed ID: 26681713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of hemodialysis-associated hypoglycemia in patients with type 2 diabetes using a continuous glucose monitoring system.
    Jung HS; Kim HI; Kim MJ; Yoon JW; Ahn HY; Cho YM; Oh KH; Joo KW; Lee JG; Kim SY; Park KS
    Diabetes Technol Ther; 2010 Oct; 12(10):801-7. PubMed ID: 20809681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of basal insulin analogues on glucose variability in patients with type 2 diabetes undergoing renal replacement therapy for end-stage renal disease.
    Savu O; Elian V; Steriade O; Teodoru I; Mihut S; Tacu C; Covic A; Serafinceanu C
    Int Urol Nephrol; 2016 Feb; 48(2):265-70. PubMed ID: 26725077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study.
    Singhsakul A; Supasyndh O; Satirapoj B
    J Diabetes Res; 2019; 2019():6923543. PubMed ID: 31828166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oral glyburide in subjects with non-insulin-dependent diabetes mellitus and renal failure.
    Brier ME; Bays H; Sloan R; Stalker DJ; Welshman I; Aronoff GR
    Am J Kidney Dis; 1997 Jun; 29(6):907-11. PubMed ID: 9186077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liraglutide narrows the range of circadian glycemic variations in Japanese type 2 diabetes patients and nearly flattens these variations in drug-naive type 2 diabetes patients: a continuous glucose monitoring-based study.
    Mori Y; Taniguchi Y; Sezaki K; Yokoyama J; Utsunomiya K
    Diabetes Technol Ther; 2011 Nov; 13(11):1139-44. PubMed ID: 21877924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients.
    Loipl J; Schmekal B; Biesenbach G
    Ren Fail; 2005; 27(3):305-8. PubMed ID: 15957547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis.
    Mirani M; Berra C; Finazzi S; Calvetta A; Radaelli MG; Favareto F; Graziani G; Badalamenti S
    Diabetes Technol Ther; 2010 Oct; 12(10):749-53. PubMed ID: 20809678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of teneligliptin in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring.
    Yajima T; Yajima K; Hayashi M; Takahashi H; Yasuda K
    Diabetes Res Clin Pract; 2016 Dec; 122():78-83. PubMed ID: 27810689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide Improves Glycemic and Blood Pressure Control and Ameliorates Progression of Left Ventricular Hypertrophy in Patients with Type 2 Diabetes Mellitus on Peritoneal Dialysis.
    Hiramatsu T; Ozeki A; Asai K; Saka M; Hobo A; Furuta S
    Ther Apher Dial; 2015 Dec; 19(6):598-605. PubMed ID: 26556397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
    Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D
    J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemia in Hospitalized Hemodialysis Patients With Diabetes: An Observational Study.
    Gianchandani RY; Neupane S; Heung M
    J Diabetes Sci Technol; 2018 Jan; 12(1):33-38. PubMed ID: 29291650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of glycemic status during the days of hemodialysis using dialysis solutions with and without glucose.
    Padmanabhan A; Velayudham B; Vijaykumar N; Allauddin S
    Saudi J Kidney Dis Transpl; 2018; 29(5):1021-1027. PubMed ID: 30381496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide improves cardiac function in patients with type 2 diabetes and chronic heart failure.
    Arturi F; Succurro E; Miceli S; Cloro C; Ruffo M; Maio R; Perticone M; Sesti G; Perticone F
    Endocrine; 2017 Sep; 57(3):464-473. PubMed ID: 27830456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.